Pasar al contenido principal

NUEVA APROXIMACION COMPUTACIONAL PARA LA CARACTERIZACION DE LOS MECANISMOS DE REGULACION DE CELULAS CANCERIGENAS DESDE DATOS DE SINGLE-CELL

PID2021-126718OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE NAVARRA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

NetActivity enhances transcriptional signals by combining gene expression into robust gene set activity scores through interpretable autoencoders

  • Ruiz Arenas, Carlos, 1990-
  • Marín Goñi, Irene
  • Wang, Liewei
  • Ochoa Álvarez, Idoia
  • Pérez Jurado, Luis Alberto
  • Hernáez, Mikel
Grouping gene expression into gene set activity scores (GSAS) provides better biological insights than studying individual genes. However, existing gene set projection methods cannot return representative, robust, and interpretable GSAS. We developed NetActivity, a machine learning framework that generates GSAS based on a sparsely-connected autoencoder, where each neuron in the inner layer represents a gene set. We proposed a three-tier training that yielded representative, robust, and interpretable GSAS. NetActivity model was trained with 1518 GO biological processes terms and KEGG pathways and all GTEx samples. NetActivity generates GSAS robust to the initialization parameters and representative of the original transcriptome, and assigned higher importance to more biologically relevant genes. Moreover, NetActivity returns GSAS with a more consistent definition and higher interpretability than GSVA and hipathia, state-of-the-art gene set projection methods. Finally, NetActivity enables combining bulk RNA-seq and microarray datasets in a meta-analysis of prostate cancer progression, highlighting gene sets related to cell division, key for disease progression. When applied to metastatic prostate cancer, gene sets associated with cancer progression were also altered due to drug resistance, while a classical enrichment analysis identified gene sets irrelevant to the phenotype. NetActivity is publicly available in Bioconductor and GitHub., MCIN/AEI/10.13039/501100011033 [TED2021-131300B-I00 C. Ruiz-Arenas, M. Hernaez]; Scientific Foundation of the Spanish Association Against Cancer [POSTD235059RUIZ to C. Ruiz-Arenas]; MCIN/AEI/10.13039/501100011033 and “European UnionNextGenerationEU/PRTR” [PID2020‐114394RA‐C33 to M. Hernaez], MCIN/AEI/10.13039/501100011033 [RYC2021- 033127-I to M. Hernaez]; Department of Defense of the US—Congressionally Directed Medical Research Programs [W81XWH-20–1-0262 to L. Wang, M. Hernaez] (in part); Mayo Clinic Center for Individualized Medicine [MC1351 to L. Wang] (in part); A.T. Suharya and D.H. Ghan (to L. Wang); Ayudas Predoctorales Gobierno de Navarra [0011-0537–2021-000106 to I. Marín-Goñi]; MCIN/AEI/10.13039/501100011033 [RYC2019-028578-I to I. Ochoa]; Gipuzkoa Fellows [2022-FELL-000003-01 to I. Ochoa]; MCIN/AEI/10.13039/501100011033 [PID2021-126718OA-I00 to I. Ochoa]. Funding for open access charge: Congressionally Directed Medical Research Programs.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

  • Patino-Garcia, Ana
  • Guruceaga, Elizabeth
  • Andueza, Maria Pilar
  • Ocón, Marimar
  • Sokoudjou, Jafait Junior Fodop
  • de Villalonga Zornoza, Nicolás
  • Alkorta-Aranburu, Gorka
  • Tamayo Uria, Ibon
  • Gurpide, Alfonso
  • Camps, Carlos
  • Navamuel-Andueza, Maria
  • Sanmamed, Miguel F.
  • Melero, Ignacio
  • Elgendy, Mohamed
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Background Tobacco is the main risk factor for developing lung cancer. Yet, while some heavy smokers develop lung cancer at a young age, other heavy smokers never develop it, even at an advanced age, suggesting a remarkable variability in the individual susceptibility to the carcinogenic effects of tobacco. We characterized the germline pro fi le of subjects presenting these extreme phenotypes with Whole Exome Sequencing (WES) and Machine Learning (ML). Methods We sequenced germline DNA from heavy smokers who either developed lung adenocarcinoma at an early age ( extreme cases ) or who did not develop lung cancer at an advanced age ( extreme controls ), selected from databases including over 6600 subjects. We selected individual coding genetic variants and variant -rich genes showing a signi fi cantly different distribution between extreme cases and controls. We validated the results from our discovery cohort, in which we analysed by WES extreme cases and controls presenting similar phenotypes. We developed ML models using both cohorts. Findings Mean age for extreme cases and controls was 50.7 and 79.1 years respectively, and mean tobacco consumption was 34.6 and 62.3 pack -years. We validated 16 individual variants and 33 variant -rich genes. The gene harbouring the most validated variants was HLA-A in extreme controls (4 variants in the discovery cohort, p = 3.46E-07; and 4 in the validation cohort, p = 1.67E-06). We trained ML models using as input the 16 individual variants in the discovery cohort and tested them on the validation cohort, obtaining an accuracy of 76.5% and an AUC-ROC of 83.6%. Functions of validated genes included candidate oncogenes, tumoursuppressors, DNA repair, HLA-mediated antigen presentation and regulation of proliferation, apoptosis, in fl ammation and immune response. Interpretation Individuals presenting extreme phenotypes of high and low risk of developing tobacco -associated lung adenocarcinoma show different germline pro fi les. Our strategy may allow the identi fi cation of high -risk subjects and the development of new therapeutic approaches., We particularly acknowledge our patients for their participation and the Biobank of the University of Navarra and Hospital General of Valencia for their collaboration. We are thankful to Dr. Paul Miller, University of Navarra, for English editing of the manuscript and to Pablo Esquiroz for fi gure editing. This work was funded by the Spanish Society of Medical Oncology, Fundacion SEOM and Fundacion Salud 2000 and by an unrestricted grant from Roche. CC and EJ work is supported by the Spanish Health Institute Carlos III (ISCII, Fondo de Investigacion Sanitaria: CB16/12/00350) . ME has received funding from the European Research Council (ERC) under Horizon 2020 research and innovation programme (Onco-Energetics_OFF, Grant agreement No. 852761) and the DFG (German Research Foundation) Project No. EL 1081/2-1. RP work is supported by the Spanish Health Institute Carlos III (ISCII, Fondo de Investigacion Sanitaria: PI20/12/00419) . This work was supported by FIMA, CIBERONC (CB16/12/00443) , Spanish Ministry of Economy and Innovation and Fondo de Investigacion Sanitaria Fondo Europeo de Desarrollo Regional (PI22/00451; to L.M. Montuenga) and Lung Ambition Alliance grant (to Luis M. Montuenga) . IO declares declares research grants and support from a Ramon y Cajal contract RYC2019-028578-I, a Gipuzkoa Fellows grant 2022-FELL-000003-01, and grant PID2021-126718OA-I00 funded by MCIN/AEI/10.13039/501100011033. MH declares research grants and support from MCIN/AEI/10.13039/501100011033 [grant number PID2020-114394RA-C33] and Ramon y Cajal contract RYC2021-033127-I.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

NetActivity enhances transcriptional signals by combining gene expression into robust gene set activity scores through interpretable autoencoders

  • Ruiz Arenas, Carlos, 1990-
  • Marín Goñi, Irene
  • Wang, Liewei
  • Ochoa Álvarez, Idoia
  • Pérez Jurado, Luis Alberto
  • Hernáez, Mikel
Grouping gene expression into gene set activity scores (GSAS) provides better biological insights than studying individual genes. However, existing gene set projection methods cannot return representative, robust, and interpretable GSAS. We developed NetActivity, a machine learning framework that generates GSAS based on a sparsely-connected autoencoder, where each neuron in the inner layer represents a gene set. We proposed a three-tier training that yielded representative, robust, and interpretable GSAS. NetActivity model was trained with 1518 GO biological processes terms and KEGG pathways and all GTEx samples. NetActivity generates GSAS robust to the initialization parameters and representative of the original transcriptome, and assigned higher importance to more biologically relevant genes. Moreover, NetActivity returns GSAS with a more consistent definition and higher interpretability than GSVA and hipathia, state-of-the-art gene set projection methods. Finally, NetActivity enables combining bulk RNA-seq and microarray datasets in a meta-analysis of prostate cancer progression, highlighting gene sets related to cell division, key for disease progression. When applied to metastatic prostate cancer, gene sets associated with cancer progression were also altered due to drug resistance, while a classical enrichment analysis identified gene sets irrelevant to the phenotype. NetActivity is publicly available in Bioconductor and GitHub., MCIN/AEI/10.13039/501100011033 [TED2021-131300B-I00 C. Ruiz-Arenas, M. Hernaez]; Scientific Foundation of the Spanish Association Against Cancer [POSTD235059RUIZ to C. Ruiz-Arenas]; MCIN/AEI/10.13039/501100011033 and “European UnionNextGenerationEU/PRTR” [PID2020‐114394RA‐C33 to M. Hernaez], MCIN/AEI/10.13039/501100011033 [RYC2021- 033127-I to M. Hernaez]; Department of Defense of the US—Congressionally Directed Medical Research Programs [W81XWH-20–1-0262 to L. Wang, M. Hernaez] (in part); Mayo Clinic Center for Individualized Medicine [MC1351 to L. Wang] (in part); A.T. Suharya and D.H. Ghan (to L. Wang); Ayudas Predoctorales Gobierno de Navarra [0011-0537–2021-000106 to I. Marín-Goñi]; MCIN/AEI/10.13039/501100011033 [RYC2019-028578-I to I. Ochoa]; Gipuzkoa Fellows [2022-FELL-000003-01 to I. Ochoa]; MCIN/AEI/10.13039/501100011033 [PID2021-126718OA-I00 to I. Ochoa]. Funding for open access charge: Congressionally Directed Medical Research Programs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide

  • Serrano, Guillermo|||0000-0003-3972-6186
  • Berastegui, Nerea|||0000-0002-9868-0547
  • Díaz-Mazkiaran, Aintzane
  • García-Olloqui, Paula|||0000-0002-7983-2875
  • Rodriguez-Res, Carmen
  • Huerga-Dominguez, Sofia
  • Ainciburu, Marina|||0000-0001-6483-1901
  • Vilas-Zornoza, Amaia|||0000-0001-6693-0989
  • Martin-Uriz, Patxi San|||0000-0003-1483-4279
  • Aguirre-Ruiz, Paula
  • Ullate-Agote, Asier|||0000-0002-8595-7703
  • Ariceta, Beñat|||0000-0001-8819-402X
  • Lamo-Espinosa, Jose-Maria
  • Acha, Pamela|||0000-0002-4528-1219
  • Calvete, Oriol|||0000-0002-2623-2876
  • Jimenez, Tamara|||0000-0001-5894-2023
  • Molero, Antonieta|||0000-0002-3735-465X
  • Montoro Gómez, Maria Julia|||0000-0001-9532-7417
  • Diez-Campelo, María|||0000-0002-1467-6779
  • Valcárcel, David|||0000-0002-8747-078X
  • Sole, F.|||0000-0002-3251-2161
  • Alfonso-Piérola, Ana|||0000-0002-2478-5354
  • Ochoa, Idoia|||0000-0003-1864-7868
  • Prosper, Felipe|||0000-0001-6115-8790
  • Ezponda, Teresa|||0000-0003-3682-7125
  • Hernaez, Mikel|||0000-0003-0443-2305
While myelodysplastic syndromes with del(5q) (del(5q) MDS) comprises a well-defined hematological subgroup, the molecular basis underlying its origin remains unknown. Using single cell RNA-seq (scRNA-seq) on CD34 + progenitors from del(5q) MDS patients, we have identified cells harboring the deletion, characterizing the transcriptional impact of this genetic insult on disease pathogenesis and treatment response. Interestingly, both del(5q) and non-del(5q) cells present similar transcriptional lesions, indicating that all cells, and not only those harboring the deletion, may contribute to aberrant hematopoietic differentiation. However, gene regulatory network (GRN) analyses reveal a group of regulons showing aberrant activity that could trigger altered hematopoiesis exclusively in del(5q) cells, pointing to a more prominent role of these cells in disease phenotype. In del(5q) MDS patients achieving hematological response upon lenalidomide treatment, the drug reverts several transcriptional alterations in both del(5q) and non-del(5q) cells, but other lesions remain, which may be responsible for potential future relapses. Moreover, lack of hematological response is associated with the inability of lenalidomide to reverse transcriptional alterations. Collectively, this study reveals transcriptional alterations that could contribute to the pathogenesis and treatment response of del(5q) MDS. The hematopoiesis of patients with del(5q) Myelodysplastic Syndromes is composed of a mixture of cells with and without the deletion. Here, the authors show that del(5q) and non-del(5q) cells share similar transcriptional alterations, with del(5q) cells presenting additional lesions. Moreover, hematological response to lenalidomide is associated with the reversal of some transcriptional lesions in both del(5q) and non-del(5q) cells.